HIVE Tests $3 Support After $350M NVIDIA AI Cloud Deal; Execution Risks Persist

What happened

HIVE Digital Technologies shares are testing the $3 level in premarket trading on August 18, 2026, after announcing a new $350 million NVIDIA-based AI cloud agreement, which adds to HIVE's BUZZ HPC pipeline. This deal follows the company's earlier disclosures of a $220 million contract for 2,304 GB200 systems and a 504 B200 cluster that went live in May 2026 at $2.90 per GPU-hour. Despite the apparently positive news, the stock is trading lower, mirroring broad market weakness as S&P 500 futures decline. The DeepValue master report had cautioned that HIVE's contracted ARR 'may be unreliable' and that the Bell teaming agreement is non-binding, and financing for the up to $493 million HPC capex plan remains uncertain. Today's price action suggests that investors are not yet convinced the new deal resolves HIVE's core execution and funding challenges, keeping the stock in a wait-and-see mode.

Implication

If the $350M NVIDIA deal includes firm commitments and favorable pricing, it could materially expand HIVE's HPC revenue potential and support a move toward the bull scenario over time. However, investors should require concrete evidence of deployment timelines, take-or-pay terms, and funding sources, given HIVE's cash position of $23.1M against a $493M capex plan. The stock's failure to rally on the announcement while testing $3 support indicates that market expectations are already elevated and that insider selling, noted in the master report, remains a concern. The previously identified attractive entry of $3.20 could become relevant again if the stock dips further on market weakness, provided the deal terms are solid. Until HIVE demonstrates sustained high utilization and premium pricing across multiple live clusters, the fundamental risk-reward does not justify an upgrade from WAIT.

Thesis delta

The new $350M NVIDIA agreement signifies a potential step-up in HIVE's AI/HPC backlog, but it does not yet translate into confirmed revenue or eliminate the financing and execution uncertainties highlighted in the master report. The investment thesis remains conditional on proof of deployment and utilization at scale, and the stock's muted reaction suggests the market has already priced in some HPC optimism. As a result, the thesis delta is neutral to slightly positive pending verification of contract terms and progress on key milestones.